We are thrilled to announce our initial public offering, trading on Nasdaq under the ticker $ALMS! This achievement wouldn't have been possible without the relentless dedication of our incredible team, as well as the support of our Board of Directors and investors. Thank you to everyone who helped us reach this critical milestone in support of our mission to improve the lives of patients with immune-mediated diseases. #NasdaqListed
🧬 Transform therapies, reimagine lives. That’s exactly what Alumis does. 🌟 $ALMS is transforming the lives of patients living with immune-mediated diseases using a precision approach to develop oral therapies. 👏 In celebration of their listing on Nasdaq, Alumis joins us for the Opening Bell. Exciting! Stay tuned for more!